Overall survival of patients <65 years of age with stage II to IV ALCL, AITL, or PTCL treated with or without consolidation with ASCT after first-line chemotherapy. See Figure 4A in the article by Brink et al that begins on page 1009.
Overall survival of patients <65 years of age with stage II to IV ALCL, AITL, or PTCL treated with or without consolidation with ASCT after first-line chemotherapy. See Figure 4A in the article by Brink et al that begins on page 1009.